Alector, Inc.

NASDAQ:ALEC

Biotechnology

Healthcare
$2.57 +5.13%

+$0.08 today

Market cap
$382.61M
Beta
0.59
P/E (TTM)
-1.4
EPS (TTM)
-$1.13
52W Low $1.09High $3.40

Volume 2.13M

Average 0.65M

ALEC Total Assets

Everything the company owns or controls; equal to total liabilities plus equity.

Alector, Inc.NASDAQ: ALEC

Total Assets · Q1 FY2026 · quarter ended Mar 2026

Total assets falls 41.2% from a year ago

Total assets stood at $239.92M at the end of Q1 FY2026, down 41.2% from a year earlier and down 18.2% from the prior quarter. Over 3 fiscal years it compounded at -28.1% a year.

Context

  • Total assets increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total assets keeps falling in the next quarterly balance sheet after a -41.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$239.92M-18.2% QoQ
Last fiscal yearDec 2025
$293.24M-37.4% YoY
Year agoMar 2025
$408.3M-41.2% since
Total Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-41.2%——
1 year-37.4%——
3-year CAGR-28.1%——
5-year CAGR——
10-year CAGR——

Total Assets history

USD · from the balance sheet

Latest · FY2025
293.24M USD
Year-over-year change
-37.4%
4-year CAGR
-22.5%

Total Assets vs competitors

How ALEC compares with its peers on the latest reported figures

  • Peers report in different currencies, so total assets is compared through growth and rates rather than absolute size.
  • Its year-over-year change of -41.2% is the lowest of 9, against a peer median of -8.8%.
  • Over three fiscal years its annual growth of -28.1% compares with a peer median of -6.1%.
ALEC Competitors
Total Assets for ALEC and competitors
Company Period Latest balance YoY 3-year CAGR
VORVor Biopharma Inc.Mar 2026$506.75M USD+363.6%+15.7%
NKTXNkarta, Inc.Mar 2026$372.07M USD-20.9%-5.1%
FATEFate Therapeutics, Inc.Mar 2026$284.92M USD-28.5%-23.3%
ALECAlector, Inc.Mar 2026$239.92M USD-41.2%-28.1%
PEPGPepGen Inc.Mar 2026$156.3M USD+22.7%-7.2%
CRBPCorbus Pharmaceuticals Holdings, Inc.Mar 2026$144.48M USD+3.3%+36.4%
ABOSAcumen Pharmaceuticals, Inc.Mar 2026$133.63M USD-34.6%-14.5%
MOLNMolecular Partners AGMar 2026CHF 87.4M CHF-38.1%-27.0%
IRDOpus Genetics, Inc.Mar 2026$66.79M USD+38.7%+0.8%
Peer median (excluding ALEC) —-8.8%-6.1%

Competitors are the stored peer set for ALEC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents329.15M154.32M74.56M33.02M65.8M
Short-term Investments406.1M558.53M474.31M380.38M190.22M
Net Receivables7.39M2.59M000
Inventory00000
Other Current Assets0016.95M11.42M10.43M
Total Current Assets749.71M726.44M565.81M424.82M266.45M
Property, Plant & Equipment (Net)57.9M53.33M47.06M37.1M24.55M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets7.05M7.88M8.96M6.39M2.23M
Total Non-current Assets64.95M61.21M56.02M43.49M26.79M
Total Assets814.66M787.65M621.83M468.3M293.24M
Account Payables4.75M4.19M3.78M2.22M1.69M
Short-term Debt0000366K
Tax Payables00000
Deferred Revenue90.8M48.23M82.98M23.66M6.68M
Other Current Liabilities11.66M12.76M54.74M54.55M24.39M
Total Current Liabilities139.56M93.81M177.95M125.06M69.5M
Long-term Debt0009.39M9.32M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)334.42M443.37M210.85M172.17M164.54M
Other Non-current Liabilities158K759K68.42M10.51M1.74M
Total Non-current Liabilities374.38M479.4M309.72M216.44M193.09M
Total Liabilities513.93M573.21M487.67M341.5M262.59M
Common Stock8K8K8K9K11K
Retained Earnings(446.38M)(579.69M)(710.08M)(829.13M)(972.06M)
Accumulated OCI(943K)(4.58M)184K261K166K
Other Stockholders Equity00000
Minority Interest00000
Total Equity300.72M214.44M134.16M126.8M30.65M
Total Debt47.6M43.33M38.92M42.52M36.23M
Net Debt(281.55M)(111M)(35.64M)9.5M(29.57M)

Alector, Inc.

NASDAQ:ALEC

Intrinsic Alpha fair value

Locked

Current Price

$2.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.